I don't want to give any advice. For me, I think the blue sky for cancer treatment is much better than slow release capsules, which I think they are still working on. Another spike? It's difficult to say. We don't really know what caused the first one. Personally, I think that if the market for Cannabis becomes more bullish AND the company reports significant results/news, this thing cold pop again. We haven't seen much news out of the company for a while, so I think that impatient traders are simply moving their money to where the action is. In their absence, I think the shorters are swooping in to try to push the price as low as possible by inducing panic. It's typical for a stock like this, imo. I'm long on the stock and I expect good things in the future. I respect that they don't run promos, and that they seem focused on the science. But whether they will ultimately succeed is anyone's guess. The S-3 was a huge benefit because it opens up the potential for easy capital. With capital in hand, they can accelerate their research. One more run, and I think they'll uplist to a senior exchange. We've seen it go to $7.00, so the potential is there.
News 
Market Data 
Discover 
AI
